Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Less May Be Enough: Clinical Equipoise for Partial Thymectomy.

The Annals of thoracic surgery·2026

Same author

SMARCA4-deficient collision papillary renal cell carcinoma and chromophobe renal cell carcinoma with long-term response to immunotherapy.

Pathology·2026

Same author

A Response to the Letter to the Editor: "Is It Time to Move Beyond Linear Measurements Toward Volumetric Assessment in Thymic Tumors?"

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

Same author

Outcomes and Toxicities of Definitive Radiation Therapy for Unresected Thymic Malignancies.

JTO clinical and research reports·2026

Same author

Feasibility and oncologic outcomes of minimally invasive surgery after induction chemoimmunotherapy for non-small cell lung cancer.

JTCVS open·2026

Same author

The 2026 American Association for Thoracic Surgery Expert Consensus Document: Evaluation and management of N2+ non-small cell lung cancer.

The Journal of thoracic and cardiovascular surgery·2026

Same journal

How to Do It: Dual Irrigation-Drainage System for Drainage and Debridement of Pancreatic Necrosis Collections.

ANZ journal of surgery·2026

Same journal

Operating Theatre Waste Generation and Segregation in a Tertiary Hospital: A Prospective Waste Audit.

ANZ journal of surgery·2026

Same journal

Delayed Loop Ileostomy Reversal Increases the Risk of Colitis and Clostridium difficile Infection.

ANZ journal of surgery·2026

Same journal

Beyond the Ringing of the Bell in Pelvic Malignancy.

ANZ journal of surgery·2026

Same journal

Amputations in Sepsis Patients: A Population-Based Cohort Study of Rates and Risk Factors.

ANZ journal of surgery·2026

Same journal

Virtual Care of Acute Diverticulitis: A Phase I/II Randomised Clinical Feasibility Trial.

ANZ journal of surgery·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Insights Into Rural Chemotherapy Usage for Muscle-Invasive Bladder Cancer: An Australian Multi-Site Institution

Tran Ngoc An Huynh¹, Samiha Arulshankar^1,2, Xinyi Wei^1,2

¹Department of Urology, Casey Hospital, Monash Health, Victoria, Australia.

ANZ Journal of Surgery

|May 22, 2025

Summary

No abstract available in PubMed .

Keywords:

adjuvant chemotherapy bladder cancer cystectomy neoadjuvant chemotherapy rural

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

Related Experiment Videos

Last Updated: Jun 27, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021